| RS1064793118 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1064793119 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064793120 |
FGFR1
|
Health Risk |
Pathogenic |
— |
| RS1064793121 |
FGFR1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793122 |
FGFR1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793123 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hartsfield-Bixler-Demyer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1064793125 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793126 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793127 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793128 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS1064793129 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS1064793130 |
FOXP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Inborn genetic diseases |
| RS1064793131 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1064793132 |
FZD4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793133 |
GABRB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793134 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1064793135 |
GDAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793136 |
GDF1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793138 |
GDF1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793139 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease |
| RS1064793140 |
GNRHR
|
Health Risk |
Likely pathogenic |
— |
| RS1064793142 |
GYS2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793143 |
GYS2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793146 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1064793147 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS1064793151 |
IGF1R
|
Health Risk |
Likely pathogenic |
— |
| RS1064793152 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS1064793154 |
IRF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Popliteal pterygium syndrome, Orofacial cleft 6 |
| RS1064793155 |
IRF6
|
Health Risk |
Likely pathogenic |
— |
| RS1064793156 |
JAK3
|
Health Risk |
Likely pathogenic |
— |
| RS1064793157 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS1064793159 |
KCNE1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 5, Long QT syndrome 5 |
| RS1064793161 |
KIF1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS1064793162 |
L1CAM
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1064793163 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS1064793164 |
L1CAM
|
Health Risk |
Likely pathogenic |
— |
| RS1064793165 |
LIAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064793167 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1064793168 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1064793169 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793170 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1064793172 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1064793173 |
MLH1
|
Health Risk |
Pathogenic |
— |
| RS1064793177 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064793178 |
MPV17
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1064793179 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colon cancer |
| RS1064793183 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Hereditary cancer-predisposing syndrome |
| RS1064793184 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793185 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal carcinoma, Hereditary nonpolyposis colorectal carcinoma |
| RS1064793188 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064793190 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS1064793194 |
MTFMT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064793196 |
MTO1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793197 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1064793198 |
MUTYH
|
Health Risk |
Likely pathogenic |
— |
| RS1064793202 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1064793203 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS1064793206 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1064793208 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal recessive nonsyndromic hearing loss 2 |
| RS1064793209 |
NAGS
|
Health Risk |
Likely pathogenic |
— |
| RS1064793210 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1064793217 |
NID1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793218 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1064793219 |
NTRK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1064793220 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1064793223 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1064793224 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS1064793225 |
PDHA1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793226 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1064793227 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1064793228 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Nonpapillary renal cell carcinoma |
| RS1064793230 |
PIGO
|
Health Risk |
Likely pathogenic |
— |
| RS1064793231 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Cardiovascular phenotype |
| RS1064793232 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793234 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064793236 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793237 |
PRPH2
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS1064793238 |
PRRT2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793243 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1064793245 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS1064793248 |
RAG1
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1064793250 |
RAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1064793251 |
RAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Atypical severe combined immunodeficiency due to complete RAG1/2 deficiency, Recombinase activating gene 2 deficiency |
| RS1064793252 |
RERE
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS1064793254 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793256 |
RYR2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793257 |
SALL1
|
Health Risk |
Pathogenic |
Townes-Brocks syndrome 1, Townes syndrome |
| RS1064793263 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 13 |
| RS1064793265 |
SEMA3A
|
Health Risk |
Likely pathogenic |
— |
| RS1064793267 |
SH3TC2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793269 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1064793271 |
SMAD4
|
Health Risk |
Pathogenic |
— |
| RS1064793273 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1064793275 |
STRA6
|
Health Risk |
Pathogenic |
— |
| RS1064793277 |
TACO1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793278 |
TGFB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793279 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793282 |
TP63
|
Health Risk |
Pathogenic |
— |
| RS1064793283 |
TP63
|
Health Risk |
Likely pathogenic |
— |
| RS1064793284 |
TPM1
|
Health Risk |
Likely pathogenic |
— |